chr3-14819311-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152536.4(FGD5):c.240C>A(p.Asp80Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000289 in 1,382,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152536.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FGD5 | NM_152536.4 | c.240C>A | p.Asp80Glu | missense_variant | 1/20 | ENST00000285046.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FGD5 | ENST00000285046.10 | c.240C>A | p.Asp80Glu | missense_variant | 1/20 | 1 | NM_152536.4 | P1 | |
FGD5 | ENST00000543601.5 | c.-484C>A | 5_prime_UTR_variant | 1/19 | 1 | ||||
FGD5 | ENST00000640506.1 | c.369C>A | p.Asp123Glu | missense_variant | 2/2 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000213 AC: 3AN: 140880Hom.: 0 AF XY: 0.0000409 AC XY: 3AN XY: 73394
GnomAD4 exome AF: 0.00000289 AC: 4AN: 1382076Hom.: 0 Cov.: 30 AF XY: 0.00000294 AC XY: 2AN XY: 679486
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2023 | The c.240C>A (p.D80E) alteration is located in exon 1 (coding exon 1) of the FGD5 gene. This alteration results from a C to A substitution at nucleotide position 240, causing the aspartic acid (D) at amino acid position 80 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at